Cart
sales@molnova.com
Doxylamine succinate
CAS No. 562-10-7
Doxylamine succinate ( NSC 74772 )
Catalog No. M15045 CAS No. 562-10-7
Doxylamine succinate competitively inhibits histamine at H1 receptors with substantial sedative and anticholinergic effects.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 45 | In Stock |
|
| 100MG | 55 | In Stock |
|
| 200MG | 92 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDoxylamine succinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDoxylamine succinate competitively inhibits histamine at H1 receptors with substantial sedative and anticholinergic effects.
-
DescriptionDoxylamine succinate competitively inhibits histamine at H1 receptors with substantial sedative and anticholinergic effects.
-
SynonymsNSC 74772
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1 receptor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number562-10-7
-
Formula Weight388.46
-
Molecular FormulaC21H28N2O5
-
Purity>98%(HPLC)
-
SolubilityEthanol: 78 mg/mL (200.79 mM); Water: 78 mg/mL (200.79 mM); DMSO: 78 mg/mL (200.79 mM)
-
SMILESCC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O
-
Chemical Namebutanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bookstaff RC, et al. Toxicol Appl Pharmacol, 1996, 141(2), 584-594.
molnova catalog
related products
-
Dimethindene maleate
Dimethindene maleate is a histamine H1 antagonist and can be used in studies about the treatment of hypersensitivity reactions, pruritus and rhinitis.
-
JNJ 39220675
JNJ 39220675 is potent and selective, brain penetrant H3 antagonist with Ki of 1.4 nM, pA2 of 9.42 for hH3.
-
Clobenpropit dihydro...
Clobenpropit dihydrobromide is a potent ?antagonist and inverse agonist of histamine H3R (histamine H3LR,pEC50 of 8.07)Clobenpropit inhibited cell migration and increased apoptosis of pancreatic cancer cells in combination with gemcitabine.?
